Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

U.S. FDA authorizes Pfizer's COVID booster shot for young children

Summary by Ground News
Pfizer requested this EUA at the end of April. Company data showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times. 4,500 children ages 5 through 11 participated in the Pfizer/BioNTech Covid-19 vaccine trial.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 61% of the sources are Center
60% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)